BSX · NYSE
Boston Scientific (BSX) Stock Price & Fundamentals
Boston Scientific (BSX) closed at $407.89 on Oct 9, 2026, up 0.94% from the previous close of $404.08.
Share price, past year
1Y +22.26%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $407.89 |
| Sep 30, 2026 | $407.12 |
| Aug 31, 2026 | $409.92 |
| Jul 31, 2026 | $407.97 |
| Jun 30, 2026 | $404.38 |
| May 29, 2026 | $403.51 |
| Apr 30, 2026 | $410.32 |
| Mar 31, 2026 | $398.43 |
| Feb 27, 2026 | $378.44 |
| Jan 30, 2026 | $369.25 |
| Dec 31, 2025 | $370.69 |
| Nov 28, 2025 | $346.04 |
| Oct 31, 2025 | $329.93 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $21.00B
- Net income (TTM)
- —
- Shares outstanding
- 1.4B
- Dividend yield
- —
- 52-week range
- $328.50 – $420.45
Financials
Boston Scientific reported revenue of $20.07B for fiscal 2025, up 19.87% from fiscal 2024.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $20.07B | +19.9% | — | — | $1.94 | $3.66B |
| FY2024ended Dec 31, 2024 | $16.75B | +17.6% | — | — | $1.25 | $2.65B |
| FY2023ended Dec 31, 2023 | $14.24B | +12.3% | — | — | $1.07 | $1.79B |
| FY2022ended Dec 31, 2022 | $12.68B | +6.7% | — | — | $0.45 | $938.00M |
| FY2021ended Dec 31, 2021 | $11.89B | +19.9% | — | — | $0.69 | $1.32B |
| FY2020ended Dec 31, 2020 | $9.91B | −7.7% | — | — | −$0.08 | $1.13B |
| FY2019ended Dec 31, 2019 | $10.74B | +9.3% | — | — | $3.33 | $1.38B |
| FY2018ended Dec 31, 2018 | $9.82B | +8.6% | — | — | $1.19 | −$6.00M |
| FY2017ended Dec 31, 2017 | $9.05B | +7.9% | — | — | $0.08 | $1.11B |
| FY2016ended Dec 31, 2016 | $8.39B | — | — | — | $0.25 | $806.00M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $5.44B | — | $0.61 |
| Q1 FY2026ended Mar 31, 2026 | $5.20B | — | $0.90 |
| Q4 FY2025ended Dec 31, 2025 | $5.29B | — | — |
| Q3 FY2025ended Sep 30, 2025 | $5.07B | — | $0.51 |
| Q2 FY2025ended Jun 30, 2025 | $5.06B | — | $0.53 |
| Q1 FY2025ended Mar 31, 2025 | $4.66B | — | $0.45 |
| Q4 FY2024ended Dec 31, 2024 | $4.56B | — | — |
| Q3 FY2024ended Sep 30, 2024 | $4.21B | — | $0.32 |
Company profile
- Name
- Boston Scientific Corporation
- Ticker
- BSX
- Exchange
- NYSE
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 300 Boston Scientific Way, Marlborough, MA 01752-1234
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000885725
Recent SEC filings
- Oct 7, 2026
- Sep 23, 2026
- Sep 8, 2026
- Aug 26, 2026
- Aug 3, 2026
- Jul 29, 2026
- Jul 27, 2026
- May 18, 2026
Frequently asked questions
What is Boston Scientific's stock price?
Boston Scientific (BSX) closed at $407.89 on Oct 9, 2026, up 0.94% from the previous close of $404.08.
How much revenue does Boston Scientific make?
Boston Scientific reported revenue of $20.07B for fiscal 2025, up 19.87% from fiscal 2024.
Does Boston Scientific pay a dividend?
Boston Scientific's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Boston Scientific Corporation's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures